Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Champions Oncology (CSBR) Shares Outstanding (2016 - 2026)

Champions Oncology (CSBR) has 12 years of Shares Outstanding data on record, last reported at $13.5 million in Q1 2022.

  • For Q1 2022, Shares Outstanding rose 0.95% year-over-year to $13.5 million; the TTM value through Jan 2022 reached $13.5 million, up 0.95%, while the annual FY2021 figure was $13.4 million, 5.4% up from the prior year.
  • Shares Outstanding reached $13.5 million in Q1 2022 per CSBR's latest filing, roughly flat from $13.5 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $13.5 million in Q1 2022 and bottomed at $269685.0 in Q2 2018.
  • Average Shares Outstanding over 5 years is $11.8 million, with a median of $12.7 million recorded in 2020.
  • Peak YoY movement for Shares Outstanding: skyrocketed 3980.03% in 2018, then rose 0.95% in 2022.
  • A 5-year view of Shares Outstanding shows it stood at $11.5 million in 2018, then grew by 1.27% to $11.6 million in 2019, then increased by 15.05% to $13.4 million in 2020, then grew by 0.95% to $13.5 million in 2021, then increased by 0.16% to $13.5 million in 2022.
  • Per Business Quant database, its latest 3 readings for Shares Outstanding were $13.5 million in Q1 2022, $13.5 million in Q4 2021, and $13.4 million in Q3 2021.